Cargando…

Exploring the Mechanism of Icariin in Osteoporosis Based on a Network Pharmacology Strategy

BACKGROUND: With the aging of the world’s population, the incidence of osteoporosis (OP) has become a public health problem of worldwide concern. Research shows that icariin may have a therapeutic effect on OP. MATERIAL/METHODS: PharmMapper was utilized to predict the potential targets of icariin. G...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Zhiyong, Wu, Jiamin, Xiang, Wang, Zeng, Zhican, Yu, Ganpeng, Li, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697664/
https://www.ncbi.nlm.nih.gov/pubmed/33230092
http://dx.doi.org/10.12659/MSM.924699
_version_ 1783615649572978688
author Long, Zhiyong
Wu, Jiamin
Xiang, Wang
Zeng, Zhican
Yu, Ganpeng
Li, Jun
author_facet Long, Zhiyong
Wu, Jiamin
Xiang, Wang
Zeng, Zhican
Yu, Ganpeng
Li, Jun
author_sort Long, Zhiyong
collection PubMed
description BACKGROUND: With the aging of the world’s population, the incidence of osteoporosis (OP) has become a public health problem of worldwide concern. Research shows that icariin may have a therapeutic effect on OP. MATERIAL/METHODS: PharmMapper was utilized to predict the potential targets of icariin. GeneCards and Online Mendelian Inheritance in Man (OMIM) were used for the collection of OP genes. The STRING database was utilized to obtain the protein-protein interaction (PPI) data. We used Cytoscape 3.7.2 to construct and analyze the networks. The genes and targets in the networks were input into the Database for Annotation, Visualization and Integrated Discovery (DAVID) to undergo Gene Ontology (GO) and pathway enrichment analysis. Finally, animal experiments were performed to verify the prediction results of this study. RESULTS: A total of 297 icariin potential targets and 262 OP genes were obtained, and an icariin-OP PPI network was constructed and analyzed. The results of the GO enrichment analysis showed that icariin can regulate the steroid hormone-mediated signaling pathway, skeletal system development, extracellular space, cytosol, and steroid hormone receptor activity. The results of the pathway enrichment analysis showed that icariin can regulate osteoclast differentiation, FoxO, estrogen, and PPAR signaling pathways. The results of the experiments showed that icariin can increase estradiol, β-catenin, and Receptor Activator of Nuclear Factor-κ B Ligand (RANKL)/osteoprotegerin (OPG) ratio in postmenopausal OP rats (P<0.05). CONCLUSIONS: This research found that the icariin can regulate OP-related biological processes, cell components, molecular functions, and signaling pathways.
format Online
Article
Text
id pubmed-7697664
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-76976642020-12-02 Exploring the Mechanism of Icariin in Osteoporosis Based on a Network Pharmacology Strategy Long, Zhiyong Wu, Jiamin Xiang, Wang Zeng, Zhican Yu, Ganpeng Li, Jun Med Sci Monit Animal Study BACKGROUND: With the aging of the world’s population, the incidence of osteoporosis (OP) has become a public health problem of worldwide concern. Research shows that icariin may have a therapeutic effect on OP. MATERIAL/METHODS: PharmMapper was utilized to predict the potential targets of icariin. GeneCards and Online Mendelian Inheritance in Man (OMIM) were used for the collection of OP genes. The STRING database was utilized to obtain the protein-protein interaction (PPI) data. We used Cytoscape 3.7.2 to construct and analyze the networks. The genes and targets in the networks were input into the Database for Annotation, Visualization and Integrated Discovery (DAVID) to undergo Gene Ontology (GO) and pathway enrichment analysis. Finally, animal experiments were performed to verify the prediction results of this study. RESULTS: A total of 297 icariin potential targets and 262 OP genes were obtained, and an icariin-OP PPI network was constructed and analyzed. The results of the GO enrichment analysis showed that icariin can regulate the steroid hormone-mediated signaling pathway, skeletal system development, extracellular space, cytosol, and steroid hormone receptor activity. The results of the pathway enrichment analysis showed that icariin can regulate osteoclast differentiation, FoxO, estrogen, and PPAR signaling pathways. The results of the experiments showed that icariin can increase estradiol, β-catenin, and Receptor Activator of Nuclear Factor-κ B Ligand (RANKL)/osteoprotegerin (OPG) ratio in postmenopausal OP rats (P<0.05). CONCLUSIONS: This research found that the icariin can regulate OP-related biological processes, cell components, molecular functions, and signaling pathways. International Scientific Literature, Inc. 2020-11-24 /pmc/articles/PMC7697664/ /pubmed/33230092 http://dx.doi.org/10.12659/MSM.924699 Text en © Med Sci Monit, 2020 This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) )
spellingShingle Animal Study
Long, Zhiyong
Wu, Jiamin
Xiang, Wang
Zeng, Zhican
Yu, Ganpeng
Li, Jun
Exploring the Mechanism of Icariin in Osteoporosis Based on a Network Pharmacology Strategy
title Exploring the Mechanism of Icariin in Osteoporosis Based on a Network Pharmacology Strategy
title_full Exploring the Mechanism of Icariin in Osteoporosis Based on a Network Pharmacology Strategy
title_fullStr Exploring the Mechanism of Icariin in Osteoporosis Based on a Network Pharmacology Strategy
title_full_unstemmed Exploring the Mechanism of Icariin in Osteoporosis Based on a Network Pharmacology Strategy
title_short Exploring the Mechanism of Icariin in Osteoporosis Based on a Network Pharmacology Strategy
title_sort exploring the mechanism of icariin in osteoporosis based on a network pharmacology strategy
topic Animal Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697664/
https://www.ncbi.nlm.nih.gov/pubmed/33230092
http://dx.doi.org/10.12659/MSM.924699
work_keys_str_mv AT longzhiyong exploringthemechanismoficariininosteoporosisbasedonanetworkpharmacologystrategy
AT wujiamin exploringthemechanismoficariininosteoporosisbasedonanetworkpharmacologystrategy
AT xiangwang exploringthemechanismoficariininosteoporosisbasedonanetworkpharmacologystrategy
AT zengzhican exploringthemechanismoficariininosteoporosisbasedonanetworkpharmacologystrategy
AT yuganpeng exploringthemechanismoficariininosteoporosisbasedonanetworkpharmacologystrategy
AT lijun exploringthemechanismoficariininosteoporosisbasedonanetworkpharmacologystrategy